Study to evaluate serum free testosterone and hsCRP concentration to predict low hematocrit in type 2 diabetes mellitus


  • Radhey Shyam Chejara Assistant Professor, Department of Medicine, SMS Medical College & Hospital, Jaipur, Rajasthan
  • C.L. Nawal Professor & Head, Department of Medicine, SMS Medical College & Hospital, Jaipur, Rajasthan
  • M.K. Agrawal Professor, Department of Medicine, SMS Medical College & Hospital, Jaipur, Rajasthan



Type 2 diabetes mellitus, Serum free testosterone levels, hs-CRP concentration, Hematocrit


Background: The primary objective of the study was to assess serum free testosterone and high sensitivity c-reactive protein concentrations and their correlation with hematocrit in patients of diabetes mellitus type 2.Hypogonadotropic hypogonadism is a common defect in type 2 diabetes, irrespective of the glycemic control, duration of disease, and the presence of complications of diabetes or obesity.It has been demonstrated that about one third of male patients with diabetes mellitus type 2 have low serum free Testosterone level.

Methods: We have included 50 patients of diabetes mellitus type 2 presenting to the department of medicine SMS Hospital Jaipur. Both indoor and out door patients were selected who were free of microalbuminuria and diabetic nephropathy. Primary or secondary hypogonadism, other than diabetes mellitus and anemia of other causes were
ruled out.

Results: Diabetes mellitus type 2 patients with low serum free testosterone levels have significantly low hematocrit values ( n= 29) (p-value <0.001) and mild anemia compared to eugonadal men ( n= 21). Their correlation was highly significant. Patients with DM type 2 who have low serum free testosterone, also have high hs-CRP concentration. Though hematocrit values were low in patients with high hs-CRP concentration but it was not statistically significant.

Conclusion: At the end of the study we concluded that both a low serum free testosterone level and high hs-CRP concentration may play an important role in the pathogenesis of mild anemia and low hematocrit values in DM type 2 patients.



B.K. Sahay. Diabetes Mellitus – Basic Considerations. Siddharth N. Shah, M. Paul Anand Eds, API Textbook of medicine, 8th edition 2008: 1042.

Vishal Bhatia, Ajay Chaudhuri, Rashmi Tomer, Sandeep Dhindsa, Husam Ghanim, Paresh Dandona et al. Low Testosterone and High C-Reactive Protein Concentrations Predict Low Hematocrit in Type 2 Diabetes. Diabetes Care, Volume 29, Number 10, October 2006,2289- 2294.

Bosman DR, Osborne CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ: Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet. Med 19:2002, 65– 69.

Dhindsa S. Prabhakar S. Sethi M, Bandyo­padhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonado­tropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89: 2004, 5462-5468.

Stephen J. Winters, David E. Kelley, and Bret Goodpaster. The analog free testosterone assay: are the results in men clinically useful? Clin Chem 44/10, 1998,2178-2182.

Yeh ET: CRP as a mediator of disease. Circulation 109: II 11-14, 2004.

Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 162: 2002, 1401–1408.

Elizabeth Selvin, Manning Feinleib, Lei Zhang, Sabine Rohrmann, Nader Rifai, William G. Nelson, et al. Androgens and Diabetes in Men. Diabetes Care 30, 2007,234-238.

Kathrine. J. Kraig, John D. Williams, Stephen G. Riley, Hilary Smith, David R. Owens, Debbie Worthing, et al Anemia and Diabetes in the Absence of Nephropathy. Diabetes care, volume 28, 2005, 1118-1123.

Merlin C. Thomas, M. Grossman, Ken Sharpe, Richard J. Madsaac, George Jerums, Sophie Clark, et al. Low testosterone and anemia in men with type 2 diabetes. Clin Endocrinol. 2009; 70(4): 547-553.

Luigi Ferrucci, Marcello Maggio, Stefania Bandinelli, Shehzad Basaria, Fulvio Lauretani, Alessandro Ble et al, Low Testosterone Levels and the Risk of Anemia in Older Men and Women. Arch Intern Medicine 2006, 166 (13), 1380-1388.

Naets JP, Wittek M. The mechanism of action of androgens on erythropoiesis. Ann N Y Acad Sci 1968; 149: 366–376.

Alex Vermeulen, Lieve Verdonck and Jean M. Kaufman. A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in serum J. Clin. Endocrinol. Metab. 1999; 84: 3666-3672.

Morley JE, Patrick P, Perry HM 3rd: Evaluation of assays available to measure free testosterone. Metabolism 2002;51: 554–559.

Ronald S Swerdloff. Free Testosterone Measurement by Analog Displacement Direct Assay: Old Concerns and New Evidence. Clin Chem 2008;54(3):458-60.




How to Cite

Chejara, R. S., Nawal, C., & Agrawal, M. (2017). Study to evaluate serum free testosterone and hsCRP concentration to predict low hematocrit in type 2 diabetes mellitus. International Journal of Research in Medical Sciences, 3(6), 1501–1504.



Original Research Articles